脂质运载蛋白
败血症
医学
炎症
铁稳态
免疫系统
免疫学
肠道菌群
先天免疫系统
平衡
生物信息学
生物
内科学
新陈代谢
作者
Fanglin Lu,Kei Inoue,Jungo Kato,Shizuka Minamishima,Hiroshi Morisaki
出处
期刊:Critical Care
[BioMed Central]
日期:2019-08-02
卷期号:23 (1): 269-269
被引量:62
标识
DOI:10.1186/s13054-019-2550-2
摘要
Lipocalin-2 (Lcn2), an innate immune protein, has come to be recognized for its roles in iron homeostasis, infection, and inflammation. In this narrative review, we provide a comprehensive description based on currently available evidence of the clinical implications of Lcn2 and its therapeutic potency in gut-origin sepsis. Lcn2 appears to mitigate gut barrier injury via maintaining homeostasis of the microbiota and exerting antioxidant strategy, as well as by deactivating macrophages and inducing immune cell apoptosis to terminate systemic hyper-inflammation. We propose that development of a therapeutic strategy targeting lipocalin-2 could be highly promising in the management of gut-origin sepsis.
科研通智能强力驱动
Strongly Powered by AbleSci AI